PYREFIN
Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists. The drugs Pyrefin is testing have myriad potential uses, including treatment for epileptic seizures. Rodent trials have shown efficacy in treatment for seizure-induced brain injury, endometriosis, and osteoarthritis without behavioral or organ toxicity after 30 days. Phase 1A of GRA’s venture development support focused Pyrefin’s team on prioritizing the clinical use of its treatment.
PYREFIN
Industry:
Biotechnology Life Science Pharmaceutical
Status:
Active
Total Funding:
100.64 K USD
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Pyrefin
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Pyrefin
More informations about "Pyrefin"
Pyrefin - Crunchbase Company Profile & Funding
Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists. The drugs Pyrefin is testing have myriad potential uses, including treatment for …See details»
Pyrefin - Funding, Financials, Valuation & Investors - Crunchbase
Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Pyrefin Inc. - VentureRadar
Pyrefin is seeking initial investment to advance its lead candidate into the clinic. VentureRadar Research / Company Website. Associated sectors: Biotechnology; Biotech; Similar …See details»
Pyrefin Inc. Company Profile | Atlanta, GA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pyrefin Inc. of Atlanta, GA. Get the latest business insights from Dun & Bradstreet.See details»
Pyrefin - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Pyrefin . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Pyrefin has 3 current employee …See details»
Georgia Research Alliance - GRA
Pyrefin is a development-stage pharmaceuticals company focused on producing EP2 receptor antagonists. The drugs Pyrefin is testing have myriad potential uses, including treatment for …See details»
Pyrefin - Drug pipelines, Patents, Clinical trials - Synapse
Explore Pyrefin with its drug pipeline, therapeutic area, technology platform, .See details»
Pyrefin Inc. - BioCentury Company Profiles - BCIQ
Pyrefin Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Pyrefin Inc. - CAGE.report
Apr 16, 2020 Pyrefin Inc. DUNS 117486017 / 11-748-6017. NCAGE Code: 8M5V1. PYREFIN INC. CAGE Code: 8M5V1. PYREFIN INC. D-U-N-S: 117486017: Company Details. …See details»
Thota Ganesh Receives ASPET Scientific Achievement …
He has ten issued patents and is co-founder of Pyrefin, Inc., a company that is developing his EP2 antagonists towards clinical trials. Dr. Ganesh is an associate professor of pharmacology and chemical biology at Emory University. He was …See details»
Faculty Highlight | Emory School of Medicine
Just recently, Dr. Ganesh co-founded a biotech company named Pyrefin, Inc., to develop treatments for brain and peripheral inflammatory conditions. Dr. Dr. Ganesh demonstrated his research experience with over 60 peer-reviewed …See details»
Pyrefin - Crunchbase
Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists.See details»
Pyrefin Company Profile -Sales, Contacts, Competitors – Buzzfile
This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products sector. This organization has been operating for …See details»
Ray Dingledine - Professor - Dept pharmacology, emory univ
Pyrefin, Inc is a small pharma company focused on developing novel anti-inflammatory drugs for epilepsy, endometriosis, arthritis and other chronic diseases. Chair, Investment CommitteeSee details»
MyD88‐mediated signaling is critical for the generation of seizure ...
Mar 12, 2024 R.D. received support from 1R01NS112308. R.D. is a named inventor on intellectual property owned by Emory University, is a co-founder and member of the Board of …See details»
Faculty Highlight | Emory School of Medicine
In 2019 he co-founded Pyrefin, Inc, and serves as Chair of its Board of Directors. He has co-authored more than 225 peer-reviewed papers and is co-inventor on eight awarded patents. …See details»
Ray Dingledine - Co-Founder & Chair of Board of Directors
Primary Organization . Pyrefin . Location Atlanta, Georgia, United States; Regions Greater Atlanta Area, East Coast, Southern US; Gender Male; Facebook View on Facebook ; LinkedIn View …See details»
Kerosene - Wikipedia
A kerosene bottle, containing blue-dyed kerosene. Kerosene, or paraffin, is a combustible hydrocarbon liquid which is derived from petroleum.It is widely used as a fuel in aviation as …See details»
Dennis McNamara - Chief Executive Officer and Co-Founder
Primary Organization . Pyrefin . Location Chapel Hill, North Carolina, United States; Regions Research Triangle, East Coast, Southern US; Gender Male; LinkedIn View on LinkedIn ; …See details»
Paraffin wax: How it’s made, why it's controversial, and what the ...
The Bayreuth Institute of Environmental Research conducted an internationally-funded study in 2007. Known as the Ökometric Wax and Emissions Study, investigators wanted to learn more …See details»